EIR Patheon Pharmaceuticals Sep 2009

Anna Brannen FDA$595.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observation (via FDA 483) on 09 Sep 2009.

Product details

  • Category:
  • Inspection end: 09 Sep 2009
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart